Reference Interval:
Effective November 14, 2011
| Negative
| No evidence of numeric chromosomal abnormalities associated with pancreatobiliary carcinoma.
| | Positive
| Contains numeric chromosomal abnormalities associated with pancreatobiliary carcinoma.
|
|
| Interpretive Data: |
Negative: A negative result indicates that none of the numeric chromosomal abnormalities commonly associated with pancreatobiliary carcinoma were identified within this specimen. A negative result does not exclude the possibility of pancreatobiliary carcinoma. In the presence of other evidence suggesting pancreatobiliary carcinoma, additional clinical studies should be considered.
Positive: A positive result indicates that one or more numeric chromosomal abnormalities commonly associated with pancreatobiliary carcinoma were identified within this specimen
Refer to Statement B under Testing Information at http://www.aruplab.com.
|
| Note: |
The UroVysion™ Kit is designed to detect aneuploidy for chromosomes 3, 7 and 17via fluorescence in situ hybridization (FISH). Results from this test are intended for use, in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of pancreatobiliary carcinoma.
|
| CPT Code(s): |
88367 x3; If manual: 88368 x3
|
Cross References: |
Bile Duct (Pancreatobiliary FISH), Bile Duct Cancer (Pancreatobiliary FISH), Cholangiocarcinoma (Pancreatobiliary FISH), FISH, Bile Duct (Pancreatobiliary FISH), FISH, Pancreas (Pancreatobiliary FISH), Pancreatic Adenocarcinoma (Pancreatobiliary FISH), Pancreatic Cancer (Pancreatobiliary FISH) |